Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Fulgent Genetics, |
RCV002475927 | SCV002803067 | pathogenic | Autosomal recessive nonsyndromic hearing loss 66; Nephronophthisis 19; Isolated neonatal sclerosing cholangitis | 2021-12-24 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV002525737 | SCV003439274 | pathogenic | Autosomal recessive nonsyndromic hearing loss 66; Isolated neonatal sclerosing cholangitis | 2022-09-02 | criteria provided, single submitter | clinical testing | This premature translational stop signal has been observed in individual(s) with neonatal sclerosing cholangitis (PMID: 27469900). For these reasons, this variant has been classified as Pathogenic. ClinVar contains an entry for this variant (Variation ID: 417768). This variant is present in population databases (no rsID available, gnomAD 0.002%). This sequence change creates a premature translational stop signal (p.Leu297*) in the DCDC2 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in DCDC2 are known to be pathogenic (PMID: 27319779, 27469900). |
OMIM | RCV000477711 | SCV000564219 | pathogenic | Isolated neonatal sclerosing cholangitis | 2017-03-28 | no assertion criteria provided | literature only |